Chief Medical Officer, Prostatype Genomics

Joined October 2009
Gerald Andriole, MD retweeted
A toast 🥂 to the 50th Anniversary of the Winter Urologic Forum! 💫 Always a great meeting! @ColumbiaUrology @UCDavisUrology Vanderbilt Urology
1
4
11
892
Gerald Andriole, MD retweeted
Phase 1 study evaluates bone metastasis resolution with SYNC-T therapy SV-102. @uropro @ProstatypeAB joins @zklaassen_md @GACancerCenter SYNC-T therapy SV-102 for metastatic prostate cancer. The treatment combines one-minute cryolysis of tumor tissue with immediate infusion of a four-component immunoadjuvant to generate tumor-specific T cell responses. #WatchNow > bit.ly/3MuSxKr
3
11
945
Gerald Andriole, MD retweeted
Thank you #SUO25. We were proud to share Phase 1 SYNC-T data showing 54% of metastatic prostate cancer patients had complete resolution of bone metastases and favorable tolerability. SYNC-T is now being studied for mCRPC in the Phase 2 LEGION-100 trial. Details: bit.ly/48jYaU5
1
1
243
Gerald Andriole, MD retweeted
#SUO25 @uropro presents SYNC-T SV-102 for mPCa 🧬 Image-guided intratumoral immunotherapy targeting 4 immune axes 👥 n=15 (Phase 1) | post-ARPI or hormone-declined | bone mets in 87% 🔹 ORR: 87% | CR: 53% 🔹 Bone mets resolved in 7/13 pts incl. >50 lesions in 1 case 🛡️ 95% Grade 1–2 AEs | no Gr 4/5 ✅ Early signal for durable, systemic immunity via local delivery @UroToday @UroOnc
4
8
711
Gerald Andriole, MD retweeted
Syncromune® Inc. Presents Positive Results from SYNC-T® Therapy SV-102 Phase 1 Metastatic Prostate Cancer Trial at ASCO 2025 - 87% ORR - 53% CR - 100% DCR - 14.2 months rPFS - 80% survival after 17.2 month median follow-up globenewswire.com/news-relea…
1
3
1,822
Gerald Andriole, MD retweeted
Stop by the Syncromune booth at #ASCO25 to learn more about our LEGION-100 Phase 2a trial of SYNC-T Therapy SV-102 for #mCRPC. Now enrolling and recruiting clinical trial sites. #LEGION100 #ProstateCancer
1
797
Gerald Andriole, MD retweeted
Please join myself with @MGuptaMD @RossKrasnow @MaxKates @KGUROmd @NathanShawMD @apolo_andrea @uropro @RyanWerntzMD @UroOncDC and more for two days of urologic oncology knowledge in our nation’s capital! medstar.cloud-cme.com/course… @MedStarHealth @LombardiCancer @GUUrology
8
1
26
4,190
Gerald Andriole, MD retweeted
In the last 9 years, the @SUO_YUO Hopkins fellows current (or soon future) jobs: OHSU Wash U Vandy Michigan Georgetown Hopkins NYU Hopkins Univ Washington #speaksforitself @SHPatelMD1 @cpavmd @nirmishsingla @allaf_mo @brady_urology
5
19
4,016
Gerald Andriole, MD retweeted
Wonderful 5 days @JHSUrology⁩. Learned a lot and made some new friendships. Look forward to coming back in the future!! Fernando Kim Margit Fisch ⁦@Brian_J_Flynn⁩ ⁦⁦@uropro⁩ ⁦@SaveYourSexLife⁩ ⁦@BovePierluigi⁩
2
3
20
3,694
Gerald Andriole, MD retweeted
JHS day3 Guidelines and Practical Applications: Artificial Urinary Sphincter – William Brant, MD Will Brant reviews AUA guidelines and tips, tricks to optimize AUS Outcomes @bsc_urology @GRUrology @kfeyer
1
3
4
622
Gerald Andriole, MD retweeted
JHS day3 Neoadjuvant therapy for MIBC in the Genomic Era – Colin P.N. Dinney, MD @GRUrology @MDAndersonNews
4
6
486
Gerald Andriole, MD retweeted
Gerry Andriole sharing his experience with prostate US imaging Prostate Microultrasound – Gerald L. Andriole, Jr., MD @GRUrology @uropro
2
3
336
Gerald Andriole, MD retweeted
Lenaine Westney sharing her/her mentors life experiences as an URM in Urology. Her Father OBGYN Chair at Howard Her mentor Ed McGuire who had a role in encouraging her and 3 other colleagues who are the 4 black-female full professors in urology "Diversity in Academic Urology"
6
7
861
Gerald Andriole, MD retweeted
Will Brant advises on the pros/cons of bicycling on erectile health "Will bicycling make you a Stallion or a Gelding? " William Brant, MD
1
5
7
751
Gerald Andriole, MD retweeted
Friday, February 3rd, 2023 JHS Day 2 Big crowd patiently awaiting ski time while enjoying state-of-the-art lectures from our international faculty
3
3
777